JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M309226200 on October 7, 2003

J. Biol. Chem., Vol. 278, Issue 51, 51243-51250, December 19, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/51/51243    most recent
M309226200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pickett, J. S.
Right arrow Articles by Fierke, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pickett, J. S.
Right arrow Articles by Fierke, C. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mutagenesis Studies of Protein Farnesyltransferase Implicate Aspartate {beta}352 as a Magnesium Ligand*

Jennifer S. Pickett{ddagger}§, Katherine E. Bowers{ddagger}, and Carol A. Fierke{ddagger}||

From the {ddagger}Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055

Protein farnesyltransferase (FTase) catalyzes the addition of a farnesyl chain onto the sulfur of a C-terminal cysteine of a protein substrate. Magnesium ions enhance farnesylation catalyzed by FTase by several hundred-fold, with a KMg value of 4 mM. The magnesium ion is proposed to coordinate the diphosphate leaving group of farnesyldiphosphate (FPP) to stabilize the developing charge in the farnesylation transition state. Here we further investigate the magnesium binding site using mutagenesis and biochemical studies. Free FPP binds Mg2+ with a Kd of 120 µM. The 10-fold weaker affinity for Mg2+ observed for the FTase·FPP·peptide ternary complex is probably caused by the positive charges in the diphosphate binding pocket of FTase. Furthermore, mutation of aspartate {beta}352 to alanine (D{beta}352A) or lysine (D{beta}352K) in FTase drastically alters the Mg2+ dependence of FTase catalysis without dramatically affecting the rate constant of farnesylation minus magnesium or the binding affinity of either substrate. In D{beta}352A FTase, the KMg increases 28-fold to 110 ± 30 mM, and the farnesylation rate constant at saturating Mg2+ decreases 27-fold to 0.30 ± 0.05 s-1. Substitution of a lysine for Asp-{beta}352 removes the magnesium activation of farnesylation catalyzed by FTase but does not significantly enhance the rate constant for farnesylation in the absence of Mg2+. In wild type FTase, Mg2+ can be replaced by Mn2+ with a 2-fold lower KMn (2 mM). These results suggest both that Mg2+ coordinates the side chain carboxylate of Asp-{beta}352 and that the role of magnesium in the reaction includes positioning the FPP prior to catalysis.


Received for publication, August 20, 2003 , and in revised form, October 7, 2003.

* This work was supported in part by National Institutes of Health Grant GM40602 (to C. A. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by National Institutes of Health Training Grant GM08597.

Supported by National Institutes of Health Postdoctoral Training Grant F32 CA84757.

|| To whom correspondence should be addressed: 930 N. University Ave., Ann Arbor, MI 48109-1055. Tel.: 734-936-2678; Fax: 734-647-4865; E-mail: fierke{at}umich.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
T. Raz, V. Nardi, M. Azam, J. Cortes, and G. Q. Daley
Farnesyl transferase inhibitor resistance probed by target mutagenesis
Blood, September 15, 2007; 110(6): 2102 - 2109.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. T. Lane and L. S. Beese
Thematic review series: Lipid Posttranslational Modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I
J. Lipid Res., April 1, 2006; 47(4): 681 - 699.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
S. F. Sousa, P. A. Fernandes, and M. J. Ramos
Farnesyltransferase--New Insights into the Zinc-Coordination Sphere Paradigm: Evidence for a Carboxylate-Shift Mechanism
Biophys. J., January 1, 2005; 88(1): 483 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. L. Hartman, K. E. Bowers, and C. A. Fierke
Lysine {beta}311 of Protein Geranylgeranyltransferase Type I Partially Replaces Magnesium
J. Biol. Chem., July 16, 2004; 279(29): 30546 - 30553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.